(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals rising 5.03% to $8.14 on Friday, following the last session’s downward trend. NASDAQ Composite fell 0.91% to $15,043.97, after five sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Today’s last reported volume for Inovio Pharmaceuticals is 6006800, 30.12% above its average volume of 4616150.
Inovio Pharmaceuticals’s last close was $8.52, 55.16% below its 52-week high of $19.00.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 311% for the present quarter and 132.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 400% and a negative 121.4%, respectively.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 72%, now sitting on 6.46M for the twelve trailing months.
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $8.14 at 17:15 EST, way under its 52-week high of $19.00 and way higher than its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s worth is below its 50-day moving average of $8.50 and below its 200-day moving average of $8.48.
More news about Inovio Pharmaceuticals (INO).